Clenbuterol antibody

Catalog No. ABIN965905

This Monoclonal antibody specifically detects in ELISA. It exhibits reactivity toward and has been mentioned in 2+ publications.

Quick Overview for Clenbuterol antibody (ABIN965905)

Target: Clenbuterol

Host: Please inquire

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: ELISA

Product Details

Specificity: Clenbuterol- KLH.

Purification: Antibodies are purified by protein G affinity chromatography.

Isotype: IgG1

Application Details

Application Notes: ELISA: Propose dilution 1: 10,000.
Determining optimal working dilutions by titration test.

Restrictions: For Research Use only

Handling

Storage: -20 °C

References

Aharoni, Dantes, Oren, Amsterdam: "cAMP-mediated signals as determinants for apoptosis in primary granulosa cells." in: Experimental cell research, Vol. 218, Issue 1, pp. 271-82, (1995) (PubMed).

Hoshi, Furutani-Seiki, Seto, Tada, Asano: "Prevention of TCR-mediated apoptosis by the elevation of cAMP." in: International immunology, Vol. 6, Issue 7, pp. 1081-9, (1994) (PubMed).

Target Details

Target: Clenbuterol

Target Type: Chemical

Background: Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. When employed as a fattening adjuvant, as compared with the therapeutic use, clenbuterol is administered in a 5 to 10 times higher dose. Therefore, it is possible that clenbuterol residues may lead to a risk for consumers after illegal administration. Using the clenbuterol monocalantibody, it is possible to detect clenbuterol and other agonists in urine, muscle and liver both rapidly and with accuracy.